Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma

doi:10.4240/wjgs.v15.i1.105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2809)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

109

WORD

HTML

926

Figures (1-2)

123

Tables (1-5)

125

Sum=1331

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

188

Download

622

Sum=810

Publishing Process of This Article

Item

Count

Browse

166

Download

502

Sum=668

Jan 27, 2023 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastrointest Surg. Jan 27, 2023; 15(1): 105-113
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105

Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival curvefor the two groups of patients. Control group: Treated with transarterial chemoembolization (TACE); Study group: Treated with TACE and radioactive iodine implantation.

Citation: Wang L, Huang K, Zhang Y, Wu YF, Yue ZD, Fan ZH, Liu FQ, Li YW, Dong J. Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(1): 105-113
URL: https://www.wjgnet.com/1948-9366/full/v15/i1/105.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.105